(Q73316438)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9139722%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Proteinase specificity and functional diversity in point mutants of plasminogen activator inhibitor 1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9139722%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9139722%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

A Gils

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9139722%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 May 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9139722%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biological Chemistry

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9139722%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

272

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9139722%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9139722%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

12662-12666

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9139722%20AND%20SRC:MED&resulttype=core&format=json

Purification and characterization of natural and recombinant human plasminogen activator inhibitor-1 (PAI-1)

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

Pathophysiology of fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

A substrate-like form of plasminogen-activator-inhibitor type 1. Conversions between different forms by sodium dodecyl sulphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

Interconversions between active, inert and substrate forms of denatured/refolded type-1 plasminogen activator inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

The latent tendencies of PAI-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

Protein inhibitors of proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

Alpha 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

Dysfunctional C1-inhibitor(At), isolated from a type II hereditary-angio-oedema plasma, contains a P1 'reactive centre' (Arg444----His) mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

Identification of tissue-type plasminogen activator-specific plasminogen activator inhibitor-1 mutants. Evidence that second sites of interaction contribute to target specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

Altered specificities of genetically engineered alpha 1 antitrypsin variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

Serpins are suicide substrates: implications for the regulation of proteolytic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

The role of conformational change in serpin structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

Engineering of plasminogen activator inhibitor-1 to reduce the rate of latency transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.19.12662

21 January 2018

Identifiers

DOI

10.1074/JBC.272.19.12662

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9139722%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference